Improved outcomes with the comprehensive stage 2 procedure after an initial hybrid stage 1

J Thorac Cardiovasc Surg. 2016 Feb;151(2):424-9. doi: 10.1016/j.jtcvs.2015.10.023. Epub 2015 Oct 23.

Abstract

Objective: To report our improving institutional experience with the hybrid alternative surgical strategy for the management of hypoplastic left heart syndrome, in which hybrid stage 1 is followed by a comprehensive stage 2 procedure (removal of patent ductus arteriosus stent and pulmonary artery [PA] bands, aorta and PA reconstruction, Damus-Kaye-Stansel, atrial septectomy, Glenn).

Methods: In this Institutional Review Board-approved retrospective review of all patients undergoing a comprehensive stage 2 procedure between January 2002 and December 2014, data were compared between the pre-protocol group (n = 64; January 2002 to March 2010) and the post-protocol group (n = 55; March 2010 to December 2014). These 2 groups flank the implementation of a perioperative management protocol to prevent PA thrombosis.

Results: Pre-protocol mortality was 19% (12 of 64), with the most common mode of death involving PA thrombosis in at least 7 patients, with an urgent indication for surgery and age as contributing factors. Care modifications instituted in March 2010 included avoidance of procedures on an emergent basis or in patients aged <3 months, use of a systemic PA shunt in cases of too-small superior vena cava and/or PA, completion angiogram with a low threshold for intraoperative stenting, and postoperative anticoagulation therapy for 6 weeks. There was a significant decrease in mortality (2 of 55; 4%; P = .01), PA thrombosis (0 of 55; 0%; P = .01), and use of extracorporeal membrane oxygenation (0/55 [0%] compared with 7 of 64 [11%]; P = .01) after protocol implementation.

Conclusions: Despite the technical challenges of the comprehensive stage 2 procedure, excellent outcomes are attainable. Experience coupled with an internal quality review drove the implementation of a successful perioperative management protocol.

Keywords: hybrid approach; hypoplastic left heart syndrome.

MeSH terms

  • Anticoagulants / therapeutic use
  • Arterial Occlusive Diseases / etiology
  • Arterial Occlusive Diseases / prevention & control
  • Extracorporeal Membrane Oxygenation
  • Female
  • Fontan Procedure* / adverse effects
  • Fontan Procedure* / mortality
  • Humans
  • Hypoplastic Left Heart Syndrome / complications
  • Hypoplastic Left Heart Syndrome / diagnosis
  • Hypoplastic Left Heart Syndrome / mortality
  • Hypoplastic Left Heart Syndrome / physiopathology
  • Hypoplastic Left Heart Syndrome / surgery*
  • Infant
  • Infant Mortality
  • Male
  • Ohio
  • Pulmonary Artery / physiopathology
  • Pulmonary Artery / surgery
  • Retrospective Studies
  • Risk Factors
  • Thrombosis / etiology
  • Thrombosis / prevention & control
  • Time Factors
  • Treatment Outcome

Substances

  • Anticoagulants